Top 10 stocks for today - 9th September, 2022

9 Sep 2022 , 07:58 AM

The Singapore Exchange’s Nifty futures traded 86 points, or 0.48%, higher at 17,905.5, indicating that stock markets may have a good start on Friday. The following 10 stocks may see significant price movement today. 

1. Mahindra & Mahindra:

The domestic auto giant, which is enthusiastic about green transportation, will debut the XUV 400, an electric sports utility vehicle, in the first few months of 2023.

1. HDFC Bank:

To finance company expansion, the private sector lender has raised Rs3,000 crore via bonds. Bonds were distributed by the bank to investors in a private placement.

1. Vodafone Idea:

The government will buy a stake in the heavily indebted telecom operator once its stock price reaches Rs10 or above. The board of Vodafone Idea (VIL) has offered the government a stake at par, or Rs10 per share.

1. Coal India:

Investors were informed by the state-owned coal miner that raising coal prices is still challenging in the current environment of rising inflation.

1. PNC Infratech:

The National Highways Authority of India (NHAI) and the civil construction company have inked a concession agreement for a HAM project with a bid project cost of Rs1,458 crore.

1. Tata Power:

Tata Power Renewable Energy, a utility company owned by the Tata Group, announced it would build a 100 MW solar power facility for Viraj Profile in Maharashtra.

1. Reliance Capital:

The debt-ridden Anil Ambani Group’s resolution process, which ended on August 29, was examined by the Committee of Creditors (CoC).

1. Future Lifestyle Fashions:

A three-month extension for convening its annual general meeting has been granted by the Registrar of Companies, according to the cash-strapped Future group’s business.

1. Reliance Power:

The board of the struggling company has given the go-ahead for a plan to issue up to Rs60 crore equity shares and/or warrants at a price of Rs15.55 per share in order to generate Rs933 crore by selling equity shares to VFSI Holdings.

1. Panacea Biotec:

The production site of the drug maker’s wholly-owned branch in Baddi in Himachal Pradesh has been asked to take additional corrective measures by the USFDA; else, clearance of any pending product applications from the plant risk  being withheld.

For feedback and suggestions, write to us at [e-mail]